PRESS RELEASE DRAFT FOR REVIEW
REF
VERSION
COPYWRITER
START DATE
DETAILS
PLANNED DISTRIBUTION
DATE
PBM/JOB/075
3
KM
22.04.14
New Panasonic MCO-170AIC incubators
May 14
NEWS RELEASE
New MCO-170AIC CO2 incubator from Panasonic demonstrates exceptional
control and optimises cell culture productivity
<date>: Etten-Leur:. New MCO-170AIC CO2 incubators from Panasonic deliver outstanding quality in
performance, maximise cell culture efficiency and provide optimum results and reproducibility.
Designed specifically for the safe, consistent cultivation of successful cell lines, this latest innovation
offers the very highest levels of precision, security and ease of use.
The MCO-170AIC CO2 incubators are designed with ease of use and work efficiency in mind.
Integrated shelf supports provide space for more culture vessels and an easy to clean incubator
interior. A new full colour LCD touch screen gives clear information of incubator status (chamber
temperature, CO2 level, door open status and alarms) with easy access to controller functions for fast,
convenient set-up. A graphical chart display allows users to quickly review incubator performance and
a new USB port allows laboratories to optimise cell culture protocols and adhere to standard
operating procedures by conveniently transferring logged data to a USB stick.
The Panasonic MCO-170AIC CO2 incubators benefit from a Direct heat and air jacket system for high
precision temperature control and rapid recovery, ensuring cultures are always maintained under
optimum conditions. A dual IR CO2 sensor maintains accurate control of critical CO2 levels by
minimising the effect of temperature and humidity changes during door opening for outstanding
performance and fast recovery. A precise culture environment is further ensured by advanced PID
control of CO2 and temperature. Enhanced insulation performance and lower energy consumption
means users can achieve improved culture conditions, along with a reduction in electrical running
costs1.
To provide optimum protection for valuable cultures, MCO-170AIC CO2 incubators incorporate
continuous background contamination control with Panasonic’s InCu saFe® copper-enriched
stainless steel interior and optional Safe Cell® UV technology, with new increased UV lamp life, which
sterilises airborne and water pan contaminants. Furthermore, the optional H2O2 vapour sterilisation
cycle provides a complete, validatable decontamination with a downtime of less than 3 hours. For
enhanced security, the incubators are also offered with a new optional electric door lock with
password.
PAN/JOB/075
Page 1 of 2
The MCO-170AIC CO2 incubator delivers a precisely controlled environment and optimum protection
for sensitive cell cultures and increased work efficiency.
For more information, please visit www.biomedical.panasonic.eu
1)
Compared to previous Panasonic 170 litre CO2 incubators
Ends
High resolution image attached or available from Claire England, Phoenix MarCom
claire.england@phoenixmarcom.co.uk Ref: PAN/JOB/075
CAPTION:
About Panasonic Biomedical Sales Europe BV (PHCBEU)
Panasonic Biomedical Europe B.V., formerly SANYO E&E Europe BV, is dedicated to life science
solutions based on end-user needs. Its biomedical products include an array of laboratory equipment
featuring industry-leading technology, controls, construction and performance. Product lines include
V.I.P. ultra-low temperature freezers, cryogenic freezers, pharmaceutical and medical refrigerators,
cell culture incubators, plant growth chambers, and portable autoclaves.
Headquartered in the Netherlands, Panasonic Biomedical Europe has sales and service organisations
in the UK, France and the Netherlands and manages sales, marketing, logistics and technical service
for Panasonic laboratory products throughout Europe. Panasonic Biomedical Europe is part of the
Panasonic Healthcare Company.
About Panasonic Healthcare
Established in 1969, Panasonic Healthcare is involved in developing, manufacturing, selling and
servicing medical equipment. It seeks to strengthen its core businesses, In Vitro Diagnostics including
self-monitoring of blood glucose systems, its Medicom businesses involved in medical IT businesses
and its life sciences based Biomedical business and to continue to pursue an important role in the
provision of optimal healthcare for all. For further information on Panasonic Healthcare please visit
http://panasonic.net/corporate/segments/phc/
For press information, please contact:
Phoenix MarCom Ltd.
Tel: +44 (0)1480 471045; Fax: +44 (0)1480 471056; claire.england@phoenixmarcom.co.uk
Please send sales enquiries to:
Panasonic Biomedical Sales Europe BV
Nijverheidsweg 120, NL-4879 AZ, Etten-Leur, The Netherlands
Tel: +31 76 543 38 33; Fax: +31 76 541 37 32; biomedical.export@eu.panasonic.com
www.biomedical.panasonic.eu
PAN/JOB/075
Page 2 of 2